Showing results (2041-2050 of 2,629) with videos related to

Sort By:
Pageof 263
The Oncologist|September 23, 2017
Sarcopenia Is Associated with Quality of Life and Depression in Patients with Advanced CancerRyan D Nipp, Georg Fuchs, Areej El-Jawahri, et al.
Biochimica Et Biophysica Acta|August 16, 1997
Phorbol myristate acetate-dependent association of protein kinase C alpha with phospholipase D1 in intact cellsT G Lee, J B Park, S D Lee, et al.
Scandinavian Journal of Rheumatology|July 27, 2001
Decreased production of interleukin-12 and interferon-gamma is associated with renal involvement in systemic lupus erythematosusD J Min, M L Cho, C S Cho, et al.
The Lancet. Oncology|April 22, 2014
MABp1, a first-in-class true human antibody targeting interleukin-1α in refractory cancers: an open-label, phase 1 dose-escalation and expansion studyDavid S Hong, David Hui, Eduardo Bruera, et al.
Cancer Chemotherapy and Pharmacology|March 11, 2017
A phase 1 study of anti-TGFβ receptor type-II monoclonal antibody LY3022859 in patients with advanced solid tumorsAnthony W Tolcher, Jordan D Berlin, Jan Cosaert, et al.
Leukemia|July 2, 2003
Ex vivo purging of leukemia cells using tumor-necrosis-factor-related apoptosis-inducing ligand in hematopoietic stem cell transplantationN-S Lee, H-J Cheong, S-J Kim, et al.
Cancer Gene Therapy|February 3, 2007
Adenovirus 5 vector genetically re-targeted by an Affibody molecule with specificity for tumor antigen HER2/neuM K Magnusson, P Henning, S Myhre, et al.
British Journal of Cancer|April 13, 2013
Feasibility of proposed single-nucleotide polymorphisms as predictive markers for targeted regimens in metastatic colorectal cancerJ C Kim, Y J Ha, S A Roh, et al.
Investigational New Drugs|June 13, 2013
Phase I clinical trial of lenalidomide in combination with sorafenib in patients with advanced cancerPrasanth Ganesan, Sarina Piha-Paul, Aung Naing, et al.
Contemporary Clinical Trials Communications|October 3, 2022
Augmenting control arms with real-world data for cancer trials: Hybrid control arm methods and considerationsW Katherine Tan, Brian D Segal, Melissa D Curtis, et al.
Pageof 263